H. pylori vaccines

References

• Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311 - 1315; PMID: 6145023; PMID: 10.1016/S0140-6736(84)91816-6
   PubMed Web of Science ®Google Scholar
• McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010; 362:1597 - 1604; PMID: 20427808; PMID: 10.1056/NEJMcp1001110
   PubMed Web of Science ®Google Scholar
• Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61:1 - 241; PMID: 7715068
   PubMedGoogle Scholar
• Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118:3030 - 3044; PMID: 16404738; PMID: 10.1002/ijc.21731
   PubMed Web of Science ®Google Scholar
• Tilg H, Kaser A. Gut microbiome, obesity and metabolic dysfunction. J Clin Invest 2011; 121:2126 - 2132; PMID: 21633181; PMID: 10.1172/JCI58109
   PubMed Web of Science ®Google Scholar
• Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, et al. Traces of human migrations in Helicobacter pylori populations. Science 2003; 299:1582 - 1585; PMID: 12624269; PMID: 10.1126/science.1080857
   PubMed Web of Science ®Google Scholar
• Kim SS, Ruiz VE, Carroll JD, Moss SF. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett 2011; 305:228 - 238; PMID: 20692762; PMID: 10.1016/j.canlet.2010.07.014
   PubMed Web of Science ®Google Scholar
• Mourad-Baars PE, Verspaget HW, Mertens BJ, Mearin ML. Low prevalence of Helicobacter pylori infection in young children in the Netherlands. Eur J Gastroenterol Hepatol 2007; 19:213 - 216; PMID: 17301647; PMID: 10.1097/MEG.0b013e328011050f
   PubMed Web of Science ®Google Scholar
• Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999; 397:176 - 180; PMID: 9923682; PMID: 10.1038/16495
   PubMed Web of Science ®Google Scholar
• Peura DA, Graham DY. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. Am J Gastroenterol 1994; 89:1137 - 1139; PMID: 8053422
   PubMed Web of Science ®Google Scholar
• Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?. Ann Intern Med 2009; 151:121 - 128; PMID: 19620164
   PubMed Web of Science ®Google Scholar
• Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcino-gens—Part B: biological agents. Lancet Oncol 2009; 10:321 - 322; PMID: 19350698; PMID: 10.1016/S1470-2045(09)70096-8
   PubMed Web of Science ®Google Scholar
• Blaser MJ. Helicobacter pylori and esophageal disease: wake-up call?. Gastroenterology 2010; 139:1819 - 1822; PMID: 21029801; PMID: 10.1053/j.gastro.2010.10.037
   PubMed Web of Science ®Google Scholar
• Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 24:1587 - 1600; PMID: 19788600; PMID: 10.1111/j.1440-746.2009.05982.x
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Bazzoli F, Delchier JC, Celinski K, Giguere M, Riviere M, et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet 2011; 377:905 - 913; PMID: 21345487; PMID: 10.1016/S0140-6736(11)60020-2
   PubMed Web of Science ®Google Scholar
• Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 2009; 104:3069 - 3079; PMID: 19844205; PMID: 10.1038/ajg.2009.555
   PubMed Web of Science ®Google Scholar
• Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL. Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol 2007; 51:577 - 586; PMID: 17919297; PMID: 10.1111/j.1574695X.2007.00338.x
   PubMed Web of Science ®Google Scholar
• Wilson KT, Crabtree JE. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 2007; 133:288 - 308; PMID: 17631150; PMID: 10.1053/j.gastro.2007.05.008
   PubMed Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161 - 1181; PMID: 8827022; PMID: 10.1097/00000478-199610000-00001
   PubMed Web of Science ®Google Scholar
• Nurgalieva ZZ, Conner ME, Opekun AR, Zheng CQ, Elliott SN, Ernst PB, et al. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun 2005; 73:2999 - 3006; PMID: 15845507; PMID: 10.1128/IAI.73.5.2999-3006.2005
   PubMed Web of Science ®Google Scholar
• Portal-Celhay C, Perez-Perez GI. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci 2006; 110:305 - 314; PMID: 16464172; PMID: 10.1042/CS20050232
   PubMed Web of Science ®Google Scholar
• Akhiani AA, Schon K, Franzen LE, Pappo J, Lycke N. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization and counteract resistance against infection. J Immunol 2004; 172:5024 - 5033; PMID: 15067084
   PubMed Web of Science ®Google Scholar
• Akhiani AA. The role of type-specific antibodies in colonization and infection by Helicobacter pylori. Curr Opin Infect Dis 2005; 18:223 - 227; PMID: 15864099; PMID: 10.1097/01.qco.0000168382.86024.14
   PubMed Web of Science ®Google Scholar
• Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, et al. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology 2009; 136:2237 - 2246 e1
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, et al. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth and contribute to pathology in mice. J Immunol 2010; 184:5121 - 5129; PMID: 20351183; PMID: 10.4049/jimmunol.0901115
   PubMed Web of Science ®Google Scholar
• Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010; 138:1046 - 1054; PMID: 19931266; PMID: 10.1053/j.gastro.2009.11.043
   PubMed Web of Science ®Google Scholar
• Velin D, Michetti P. Advances in vaccination against Helicobacter pylori. Expert Rev Gastroenterol Hepatol 2010; 4:157 - 166; PMID: 20350263; PMID: 10.1586/egh.10.6
   PubMed Web of Science ®Google Scholar
• Hitzler I, Becher B, Agger EM, Muller A. Dendritic cells prevent rather than promote immunity conferred by a Helicobacter vaccine using a mycobacterial adjuvant. Gastroenterology 2011; 141:186 - 196; PMID: 21569773; PMID: 10.1053/j.gastro.2011.04.009
   PubMed Web of Science ®Google Scholar
• Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, et al. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006; 131:525 - 537; PMID: 16890606; PMID: 10.1053/j.gastro.2006.05.001
   PubMed Web of Science ®Google Scholar
• Czinn SJ, Blanchard T. Vaccinating against Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 2011; 8:133 - 140; PMID: 21304478; PMID: 10.1038/nrgastro.2011.1
   PubMed Web of Science ®Google Scholar
• Ghiara P, Rossi M, Marchetti M, Di Tommaso A, Vindigni C, Ciampolini F, et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun 1997; 65:4996 - 5002; PMID: 9393788
   PubMed Web of Science ®Google Scholar
• Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, et al. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. Vaccine 2009; 27:5013 - 5019; PMID: 19446591; PMID: 10.1016/j.vaccine.2009.05.009
   PubMed Web of Science ®Google Scholar
• Cuenca R, Blanchard TG, Czinn SJ, Nedrud JG, Monath TP, Lee CK, et al. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology 1996; 110:1770 - 1775; PMID: 8964402; PMID: 10.1053/gast.1996.v110. pm8964402
   PubMed Web of Science ®Google Scholar
• Nedrud JG. Animal models for gastric Helicobacter immunology and vaccine studies. FEMS Immunol Med Microbiol 1999; 24:243 - 250; PMID: 10378428; PMID: 10.1111/j.1574-695X.1999.tb01290.x
   PubMed Web of Science ®Google Scholar
• Lee CK, Soike K, Giannasca P, Hill J, Weltzin R, Kleanthous H, et al. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine 1999; 17:3072 - 3082; PMID: 10462242; PMID: 10.1016/S0264-410X(99)00144-9
   PubMed Web of Science ®Google Scholar
• Lee CK, Soike K, Hill J, Georgakopoulos K, Tibbitts T, Ingrassia J, et al. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine 1999; 17:1493 - 1505; PMID: 10195786; PMID: 10.1016/S0264-410X(98)00365-X
   PubMed Web of Science ®Google Scholar
• Graham DY, Opekun AR, Osato MS, El-Zimaity HM, Lee CK, Yamaoka Y, et al. Challenge model for Helicobacter pylori infection in human volunteers. Gut 2004; 53:1235 - 1243; PMID: 15306577; PMID: 10.1136/gut.2003.037499
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Selgrad M, Wex T, Del Giudice G, Palla E, Graham D, et al. Acute infection with a Cag A positive H. pylori strain in healthy subjects-effect on symptoms and gastric physiology. Gastroenterology 2011; 140:S86
   Web of Science ®Google Scholar
• Israel DA, Salama N, Krishna U, Rieger UM, Atherton JC, Falkow S, et al. Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci USA 2001; 98:14625 - 14630; PMID: 11724955; PMID: 10.1073/pnas.251551698
   PubMed Web of Science ®Google Scholar
• Moss SF, Moise L, Lee DS, Kim W, Zhang S, Lee J, et al. HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine 2011; 29:2085 - 2091; PMID: 21236233; PMID: 10.1016/j.vaccine.2010.12.130
   PubMed Web of Science ®Google Scholar
• Committee to study priorities for vaccine development, division of health promotion and disease prevention, Institute of Medicine. Stratton KR, Durch JS, Lawrence RS. Appendix 7: Helicobacter pylori. Vaccines for the 21^st century: a tool for decisionmaking 2000; Washington DC National Academies Press 181 - 188
   Google Scholar
• Rupnow MF, Chang AH, Shachter RD, Owens DK, Parsonnet J. Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States. J Infect Dis 2009; 200:1311 - 1317; PMID: 19751153; PMID: 10.1086/605845
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SH, Ulrichs T, Novicki D, et al. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology 2008; 135:787 - 795; PMID: 18619971; PMID: 10.1053/j.gastro.2008.05.054
   PubMed Web of Science ®Google Scholar